Nanotechnology in the diagnosis and treatment of stroke.
Nanotechnology in the diagnosis and treatment of stroke.
复制标题
DOI:
10.1016/j.drudis.2020.11.018
复制
发表时间:
2020-11
影响因子:
7.4
通讯作者:
Deepaneeta Sarmah;Mainak Banerjee;Aishika Datta;K. Kalia;S. Dhar;D. Yavagal;P. Bhattacharya
中科院分区:
文献类型:
--
作者:
Deepaneeta Sarmah;Mainak Banerjee;Aishika Datta;K. Kalia;S. Dhar;D. Yavagal;P. Bhattacharya
HighlightsNanotechnology has not only opened a new window for the delivery of drugs for stroke therapy but also has improved and eased stroke diagnosis.Nanoparticles made from gold, iron oxide, perfluorocarbon, polymers and quantum dots may be robustly employed for stroke diagnosis and therapy.Biocompatibility and safety concerns of nanoparticles may be overcome and enhanced by structural modification or by coating.Increasing developments in the field of nanotechnology have ignited its use in stroke diagnosis and treatment. The benefits of structural modification, ease of synthesis, and biocompatibility support the use of nanomaterials in the clinic. The pathophysiology of stroke is complex, involving different brain regions; hence, therapeutic agents are required to be delivered to specific regions. Nanoparticles (NPs) can be engineered to help improve the delivery and release of therapeutic agents in a localized manner, especially in the penumbra. This contributes not only to therapy, but also to neurosurgery and neuroimaging. Nanomaterials also offer high efficacy with few adverse effects. In this review, we provide a concise summary of the caveats associated with nanotechnology with respect to stroke therapy and diagnosis.